National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources
skip sub-navigation, go to content.

Breast and Gynecologic Cancer Research Group

Programs and Projects

Cervical Cancer Clinical Trials

Ongoing Phase II Prevention Trials Monitored by the Breast and Gynecologic Cancer Research Group (BGCRG)

Contracts

Principal Investigator Institution Title of Award Chemopreventive Agent BGCRG Medical Monitor
Francisco Garcia, MD** University of Arizona A Phase II Trial of Polyphenon E for Cervical Cancer Green Tea Catechins Terri Cornelison, M.D.
Brad Monk, M.D.
Dorothy Wiley, M.D.
Univ. of California, Irvine An Exploratory Study to Evaluate the Effect of HPV-16 Vaccine on the Reduction of Viral Load in HPV-16 Positive Women with Persistent Viral Infection, but Low Grade Disease (ASCUS/LSIL) HSP-E7 Vaccine Terri Cornelison, M.D.

** indicates that the contract/cooperative agreements are open to accrual

This page was last updated on May 18, 2006.